Ample evidence suggests there is increased inflammation in patients with depression, and the reduced KYNA/3-HK ratio in patients with depression further confirms this, suggesting that the KMO pathway is activated as a result of depression [30]. The gene discussed is KMO; the disease is depressive symptom measurement.